Outlook Therapeutics, Inc. OTLK 深 滬
等待開盤 06-26 09:30:00 美东时间
1.61
-0.070
-4.17%
華盛通- 最 高1.7202
- 今 開1.66
- 成交量 887.56万股
- 最 低 1.54
- 昨 收 1.68
- 總市值 2.58亿
- 52周最高 3.39
- 市盈率 靜 --
- 換手率 5.54%
- 52周最低 0.1611
- 委 比 -73.67%
- 總股本 1.60亿
- 歷史最高 219.20
- 量 比 0.54
- 振 幅 10.73%
- 歷史最低 0.1611
- 每 手 1
- 風險率 0.73%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股牛股 | LPRO大涨超48%，获保险经纪平台ANV溢价要约收购；OTLK涨超35%
LPRO大涨超48%，获保险经纪平台ANV溢价要约收购；OTLK涨超35%，核心产品许可申请获FDA重新受理；LION涨近14%，奈飞有意收购该公司>>
06-17 15:55
Outlook Therapeutics’ Resubmitted ONS-5010 BLA Accepted by FDA
Outlook Therapeutics ( ($OTLK) ) has provided an update. On June 16, 2026, Outl...
06-16 21:49
Outlook gains as wet AMD therapy reconsidered for FDA review
Outlook Therapeutics (OTLK) traded higher in the premarket on Tuesday after the U.S. Food and Drug Administration agreed to reconsider its marketing application for ONS-5010, a treatment targeting the...
06-16 21:23
美股牛股 | SpaceX拟上升点燃太空概念行情！维珍银河大涨21%；OTLK大涨23%
ATEX飙升25%，现金收入大超预期，频谱资产货币化成效显著；OTLK大涨23%，获机构大幅上调OTLK目标价；太空概念集体“起飞”！维珍银河大涨21%>>
06-12 16:13
美股大行评级 | 甲骨文绩后分歧大！5家上调，2家下调；Navan、Hinge Health、凯西通用获多家大行上调目标价
今日重点评级关注：Ascendiant Capital：维持Outlook Therapeutics"买入"评级，目标价从6美元升至10美元；Ascendiant Capital：维持Aytu BioPharma"买入"评级，目标价从14美元升至14.5美元
06-12 11:32
Intel To Rally Around 26%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. BTIG raised the price target for Chefs’ Warehouse Inc (NASDAQ:CHEF) from $82 to $100. BTIG analyst Peter Saleh...
06-11 19:49
Ascendiant Capital Maintains Buy on Outlook Therapeutics, Raises Price Target to $10
Ascendiant Capital analyst Edward Woo maintains Outlook Therapeutics (NASDAQ:OTLK) with a Buy and raises the price target from $6 to $10.
06-11 17:46
美股牛股 | 新股PBLS大涨58%，此前获10倍超购募资7.45亿美元；凯西通用零售涨逾20%
新股PBLS大涨58%，此前获10倍超购募资7.45亿美元；FAC大涨37%，近日完成SPAC合并登陆纳斯达克；凯西通用零售涨逾20%，Q4业绩超预期并大幅上调股息>>
06-11 16:35
Outlook Therapeutics Resubmits FDA Application for ONS-5010
Outlook Therapeutics ( ($OTLK) ) has provided an announcement. On June 1, 2026,...
06-01 22:40
Outlook Therapeutics Announces Insider-Backed Direct Stock Offering
Outlook Therapeutics ( ($OTLK) ) has issued an announcement. On May 28, 2026, O...
05-29 06:48
